N/A
Completed N=5
UVA Light Device to Treat COVID-19
Coronavirus
Source: ClinicalTrials.gov NCT04572399 ↗
Enrolled (actual)
5
Serious AEs
0.0%
Results posted
Jan 2022
Primary outcomePrimary: Negative Change in Viral Load — 3.2 log10 copies/mL
Summary
This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Negative Change in Viral Load |
3.2 | — |
| SECONDARY Change in Bacterial Load |
102000 | — |
| SECONDARY Ventilated Associated Pneumonia |
1 | — |
| SECONDARY Days to Extubation |
20.75 | — |
| SECONDARY Days to Discharge |
27.25 | — |
| SECONDARY Change in C-reactive Protein |
95.00 | — |
| SECONDARY Change in the World Health Organization (WHO) Coronavirus Disease (COVID)-19 10-point Ordinal Severity Scale by 30 Days |
3.6 | — |
| SECONDARY Catheter Tip Assessment on the Last Day of Treatment |
— | — |
Eligibility Criteria
Inclusion Criteria
- Confirmed positive test result for SARS-CoV-2
- Mechanically ventilated
- Endotracheal tube inner diameter of at least 7.5 mm
Exclusion Criteria
- Unable to provide informed consent (or surrogate)
- Enrolled in a therapeutic clinical trial for same condition that does not allow recruitment in other trials
- Pregnant women
Data sourced from ClinicalTrials.gov (NCT04572399). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.